EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-Modal Design, Synthesis, and Biological Evaluation of Novel Fusidic Acid Derivatives

Luqi Wang, Zhiyuan Geng, Yuhang Liu, Linhui Cao, Yao Liu, Hourui Zhang, Yi Bi iD, Jing Lu

Molecules · 2025

DOI: 10.3390/molecules30091983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Luqi Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation…. Hauptthemen laut MEDLINE: Fusidic Acid, Anti-Bacterial Agents, Drug Design. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Natural Science Foundation, the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fusidic acid (FA), a tetracyclic triterpenoid, has been approved to treat methicillin-resistant Staphylococcus aureus (MRSA) infections. However, there are few reports about FA derivatives with high efficacy superior to FA, manifesting the difficulty of discovering the derivatives based on experience-based drug design. In this study, we employed a stepwise method to discover novel FA derivatives. First, molecular dynamics (MD) simulations were performed to identify the molecular mechanism of FA against elongation factor G (EF-G) and drug resistance. Then, we utilized a scaffold decorator to design novel FA derivatives at the 3- and 21-positions of FA. The ligand-based and structure-based screening models, including Chemprop and RTMScore, were employed to identify promising hits from the generated set. Ten generated FA derivatives with high efficacy in the Chemprop and RTMScore models were synthesized for in vitro testing. Compounds 4 and 10 demonstrated a 2-fold increase in potency against MRSA strains compared to FA. This study highlights the significant impact of AI-based methods on the design of novel FA derivatives with drug efficacy, which provides a new approach for drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fusidic AcidAnti-Bacterial AgentsDrug DesignMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular Dynamics SimulationStructure-Activity RelationshipPeptide Elongation Factor GMolecular StructureHumans

Stichwörter der Autor:innen

AI-based drug design and screeningfusidic acid derivativein vitro modelmolecular dynamics simulation

Substanzen

Fusidic AcidAnti-Bacterial AgentsPeptide Elongation Factor G

Autor:innen und Institutionen

  • School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universi…

ORCID-Profile: Yi Bi

Förderung

  • Shandong Provincial Natural Science Foundation
  • the National Natural Science Foundation of China

Zitieren

APA

Wang, L., Geng, Z., Liu, Y., Cao, L., Liu, Y., Zhang, H., Bi, Y., & Lu, J. (2025). Multi-Modal Design, Synthesis, and Biological Evaluation of Novel Fusidic Acid Derivatives. Molecules. https://doi.org/10.3390/molecules30091983

Vancouver

Wang L, Geng Z, Liu Y, Cao L, Liu Y, Zhang H, et al. Multi-Modal Design, Synthesis, and Biological Evaluation of Novel Fusidic Acid Derivatives. Molecules. 2025. doi:10.3390/molecules30091983

BibTeX
@article{Wang2025,
  author = {Wang, Luqi and Geng, Zhiyuan and Liu, Yuhang and Cao, Linhui and Liu, Yao and Zhang, Hourui and Bi, Yi and Lu, Jing},
  title = {Multi-Modal Design, Synthesis, and Biological Evaluation of Novel Fusidic Acid Derivatives},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30091983}
}
Kostenlos starten →